Literature DB >> 28592956

Prevalence and incidence of interatrial block in global population and in different clinical situations.

Manuel Martínez-Sellés1.   

Abstract

Entities:  

Keywords:  Epidemiology; Incidence; Interatrial block; Prevalence

Year:  2017        PMID: 28592956      PMCID: PMC5460059          DOI: 10.11909/j.issn.1671-5411.2017.03.006

Source DB:  PubMed          Journal:  J Geriatr Cardiol        ISSN: 1671-5411            Impact factor:   3.327


× No keyword cloud information.

Introduction

The high prevalence of interatrial block (IAB) is widely neglected due to its frequent underdiagnosis. Its prevalence depends mainly on age and also on the presence of associated heart disease. In patients without structural heart disease, it is mainly an elderly condition. This is particularly true for advanced IAB, rarely found in global population before 65 years but with prevalence of 8% in the 70's and 25% in centenarians.[1] When studying prevalence data of this condition, three factors should be taken into account in order to interpret differences that are frequently related with the methodology used (Table 1, Figure 1).[2],[3]
Table 1.

Factors to be taken into account when studying prevalence data of interatrial block.

- Studies published before the 2012 consensus frequently use the cut-off of 110 ms instead of the correct one (120 ms).[2]- Several studies use only one ECG lead (II) or the lead with the longest P wave instead of selecting the first initiation of P wave and the last finish in any lead (Figure 1).[3]- The measurement methods of P wave length vary between studies (automatic, semiautomatic, manual).
Figure 1.

The method to measure the P wave duration is to quantify the difference between the first (F) start of the P wave and the end (E) in the last one.[3]

In this case, lead III is the lead that shows first the start of P wave and VF is the last one that records the end of P wave.

Why is the prevalence of interatrial block increasing

IAB is already pandemic mainly due to two reasons. The first one is population ageing.[4] Worldwide, the fraction of individuals > 60 years increased from 9% in 1990 to 12% in 2013 and is projected to reach 21% (> 2 billion) by 2050.[4] Ageing increases not only the rate of elderly population but also the prevalence of cardiovascular disease, as ageing affects extensively the heart and specifically modifies the specialized cardiac conducting system.[5] The second reason is that the recent advances in the management of cardiac conditions—including ischemic heart disease, valvular heart disease, and heart failure—is increasing the survival of these patients, most of whom already have IAB or will acquire it during the course of their disease.[6]

Association with age: total prevalence and prevalence in those that remain in sinus rhythm

It is well known that the prevalence of atrial fibrillation increases with age,[7],[8] and this is also the case with IAB,[7]–[13] in both cases in probable association with the degree of atrial fibrosis.[14] P-wave duration is correlated to age, even during infancy.[15] This is why IAB is practically inexistent in healthy children,[15] and rare in young adults,[16] except in the case of cryptogenic stroke and patent foramen ovale.[17] Cotter, et al.,[17] found a prevalence of only 16% in a control group with a mean age of 37 years. However, in the group of patients with mean age 41 years that presented cryptogenic stroke and patent foramen ovale, the prevalence increased to 46%. IAB prevalence in global population is mainly an issue in the elderly.[13] Also in the elderly, IAB increases with age. In septuagenarians the prevalence is almost 40%,[1],[18] and is over the rate of 50% in octogenarians.[13] The fact that IAB is an elderly condition is even clearer in the case of advanced IAB. In the Atherosclerosis Risk in Communities (ARIC) study performed in a global population with mean age of 54 years,[19] only 0.5% had advanced IAB at baseline, but the effect of the age was clear as 1.3% developed advanced IAB during the mean 6-year follow-up. These authors found an incidence for advanced IAB of 2.3 per 1000 person-years. However, the rate of atrial fibrillation shows a similar increase with age, this is why if we focus in all the elderly population, the increase in IAB can be confounded by the increase in atrial fibrillation. In fact, if we study only subjects who persist in sinus rhythm, the association of age with IAB is clearly stronger. When we consider the extreme age of centenarians, about one quarter of them have atrial flutter/fibrillation, and a similar number have normal P wave, partial IAB, and advanced IAB.[1] Finally, as happens with atrial fibrillation and IAB, atrial premature beats and runs of atrial arrhythmias are also associated with age, and its incidence is higher in subjects with IAB than in those with normal P wave, and in those with advanced vs. partial IAB.[1]

The method to measure the P wave duration is to quantify the difference between the first (F) start of the P wave and the end (E) in the last one.[3]

In this case, lead III is the lead that shows first the start of P wave and VF is the last one that records the end of P wave.

Association with heart disease

The prevalence of advanced IAB is reported to be around 1% in patients with structural heart disease, including valvular heart disease.[19] In the Cardiac and Clinical Characterisation of Centenarians registry, centenarians with IAB had a rate of significant mitral regurgitation that fell between the ranges observed in individuals with a normal P wave and those with atrial fibrillation/flutter (Figure 2), suggesting that this heart valve disease could play a potential role in triggering IAB, and later, atrial fibrillation.[1]
Figure 2.

Rate of significant mitral regurgitation in the cardiac and clinical characterization of centenarians (4C) registry.

This figure has been performed with data from Martínez-Sellés, et al.[1] AF: atrial fibrillation; IAB: interatrial block.

Previous studies have reported a much higher prevalence of advanced IAB in subjects with heart failure and also in those with ischemic heart disease. Sadiq, et al.,[20] found advanced IAB in 38% heart failure patients undergoing cardiac resynchronization therapy, and we found this condition in 17% of patients admitted with heart failure that had sinus rhythm.[21] Interestingly, in our patients, the rate of partial IAB was extremely high (64%), as only 18% presented a normal P-wave (Figure 3). In a population of patients undergoing coronary bypass graft surgery with a mean age of 65 years, Conde, et al.,[22] found an IAB prevalence of 36% (partial 22%, advanced 14%).
Figure 3.

Prevalence of IAB in patients admitted with heart failure that are in sinus rhythm.

This figure has been performed with data from Avarez García, et al.[21] IAB: interatrial block.

Rate of significant mitral regurgitation in the cardiac and clinical characterization of centenarians (4C) registry.

This figure has been performed with data from Martínez-Sellés, et al.[1] AF: atrial fibrillation; IAB: interatrial block.

Prevalence of IAB in patients admitted with heart failure that are in sinus rhythm.

This figure has been performed with data from Avarez García, et al.[21] IAB: interatrial block. IAB is also frequently found in unselected populations of hospitalized patients and of outpatients, with rates of 35%–45%.[23]–[26] IAB prevalence is even higher in patients with other diseases as hypertension,[13] Friedreich's ataxia,[27] obstructive sleep apnea,[28] and stroke.[29] In a group of patients with typical atrial flutter treated with cavotricuspid isthmus ablation (mean age 67 years), the prevalence of advanced IAB was 18%;[30] and a similar rate was found in patients with recent onset atrial fibrillation without structural heart disease (mean age 58 years) that underwent successful pharmacological cardioversion.[31] In patients with sinus node dysfunction who were implanted dual chamber pacemaker, the prevalence of IAB is also high (32%).[32] In conclusion, the prevalence of atrial fibrillation increases with age and is higher in the presence of heart disease and this is also true for IAB, a pre-atrial fibrillation condition associated with premature atrial beats. This data suggest that screening for IAB and atrial fibrillation should be performed in the elderly.
  31 in total

1.  Exceptional prevalence of interatrial block in a general hospital population.

Authors:  U C Jairath; D H Spodick
Journal:  Clin Cardiol       Date:  2001-08       Impact factor: 2.882

2.  Prevalence of interatrial block in the Program of All-Inclusive Care for the Elderly (PACE).

Authors:  Vignendra Ariyarajah; Puneet Puri; Mark Kranis; David A Wilner; David H Spodick
Journal:  Am J Geriatr Cardiol       Date:  2006 May-Jun

Review 3.  Interatrial block: a prevalent, widely neglected, and portentous abnormality.

Authors:  David H Spodick; Vignendra Ariyarajah
Journal:  J Electrocardiol       Date:  2007-05-24       Impact factor: 1.438

4.  Prevalence of interatrial block in young healthy men<35 years of age.

Authors:  Elias Gialafos; Theodora Psaltopoulou; Theodore G Papaioannou; Andreas Synetos; Polychronis Dilaveris; George Andrikopoulos; Konstantinos Vlasis; John Gialafos; Christodoulos Stefanadis
Journal:  Am J Cardiol       Date:  2007-07-05       Impact factor: 2.778

5.  Prevalence of interatrial block in patients undergoing coronary bypass graft surgery.

Authors:  Diego Conde; Erik M van Oosten; Andrew Hamilton; Dimitri Petsikas; Darrin Payne; Damian P Redfearn; Wilma M Hopman; Antoni Bayés de Luna; Adrian Baranchuk
Journal:  Int J Cardiol       Date:  2013-12-11       Impact factor: 4.164

6.  Advanced Interatrial Block Predicts New Onset Atrial Fibrillation in Patients with Severe Heart Failure and Cardiac Resynchronization Therapy.

Authors:  Fariha Sadiq Ali; Andres Enriquez; Diego Conde; Damian Redfearn; Kevin Michael; Christopher Simpson; Hoshiar Abdollah; Antoni Bayés de Luna; Wilma Hopman; Adrian Baranchuk
Journal:  Ann Noninvasive Electrocardiol       Date:  2015-02-02       Impact factor: 1.468

Review 7.  Age-associated changes in cardiovascular structure and function: a fertile milieu for future disease.

Authors:  Jerome L Fleg; James Strait
Journal:  Heart Fail Rev       Date:  2012-09       Impact factor: 4.214

8.  New-onset atrial fibrillation after cavotricuspid isthmus ablation: identification of advanced interatrial block is key.

Authors:  Andres Enriquez; Axel Sarrias; Roger Villuendas; Fariha Sadiq Ali; Diego Conde; Wilma M Hopman; Damian P Redfearn; Kevin Michael; Christopher Simpson; Antoni Bayés De Luna; Antoni Bayés-Genís; Adrian Baranchuk
Journal:  Europace       Date:  2015-02-10       Impact factor: 5.214

9.  Interatrial block and atrial arrhythmias in centenarians: Prevalence, associations, and clinical implications.

Authors:  Manuel Martínez-Sellés; Albert Massó-van Roessel; Jesús Álvarez-García; Bernardo García de la Villa; Alfonso J Cruz-Jentoft; María Teresa Vidán; Javier López Díaz; Francisco Javier Felix Redondo; Juan Manuel Durán Guerrero; Antoni Bayes-Genis; Antonio Bayes de Luna
Journal:  Heart Rhythm       Date:  2015-10-28       Impact factor: 6.343

10.  The challenges of human population ageing.

Authors:  Miriam Sander; Bjarke Oxlund; Astrid Jespersen; Allan Krasnik; Erik Lykke Mortensen; Rudi Gerardus Johannes Westendorp; Lene Juel Rasmussen
Journal:  Age Ageing       Date:  2014-12-01       Impact factor: 10.668

View more
  4 in total

1.  Interatrial block predicts atrial fibrillation in patients with carotid and coronary artery disease.

Authors:  Bryce Alexander; Adrian Baranchuk; Sohaib Haseeb; Henri van Rooy; Adrian Kuchtaruk; Wilma Hopman; Göksel Çinier; Marie-France Hetu; Terry Y Li; Amer M Johri
Journal:  J Thorac Dis       Date:  2018-07       Impact factor: 2.895

Review 2.  Atrial Conduction Disorders.

Authors:  Bryce Alexander; Gary Tse; Manuel Martinez-Selles; Adrian Baranchuk
Journal:  Curr Cardiol Rev       Date:  2021

3.  Advanced Interatrial Block Predicts Recurrence of Atrial Fibrillation and Ischemic Stroke in Elderly Patients With Hypertension.

Authors:  Haijun Wang; Lili Cai; Yan Guo; Li Shuai; Yang Shi; Quanjin Si
Journal:  Front Physiol       Date:  2022-06-16       Impact factor: 4.755

4.  Interatrial blocks prevalence and risk factors for human immunodeficiency virus-infected persons.

Authors:  Francisco Fanjul; Antoni Campins; Javier Asensio; Gloria Sampériz; Aina Yañez; Dora Romaguera; Miquel Fiol; Melchor Riera
Journal:  PLoS One       Date:  2019-10-17       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.